IL-2 Superkine (monomeric):Fc-KIH (human) (rec.)

IL-2 Superkine (monomeric):Fc-KIH (human) (rec.)
Item number Size Datasheet Manual SDS Delivery time Quantity Price
AG-40B-0222-C010 10 µg -

3 - 9 business days*

429.00€
AG-40B-0222-3010 30 µg (3 x 10 µg) -

3 - 9 business days*

858.00€
AG-40B-0222-C100 100 µg -

3 - 9 business days*

1,870.00€
 
Interleukin-2 (IL-2) is a 133 amino acid glycoprotein with one intramolecular disulfide bond and... more
Product information "IL-2 Superkine (monomeric):Fc-KIH (human) (rec.)"
Interleukin-2 (IL-2) is a 133 amino acid glycoprotein with one intramolecular disulfide bond and variable glycosylation. It is secreted by activated T cells and induces proliferation and maturation of activated T cells, natural killer cells and lymphokine activated killer cells. IL-2 also stimulates proliferation of antibody-producing B cells, activates neutrophils and induces mononuclear cells to secrete IFN-gamma and TNF-alpha and -beta. Moreover, studies have shown that IL-2 is required for activation-induced apoptosis, an important homeostatic mechanism in the immune system, which is involved in the maintenance of peripheral tolerance to self-antigens. IL-2 promotes T cell proliferation and particularly naive T cells. IL-2 signaling on activated T cells is effected through a quaternary high-affinity receptor complex consisting of IL-2, IL-2Ralpha (CD25), IL-2Rbeta and IL-2Rgamma. Naive T cells are relatively insensitive to IL-2 as they only express small amounts of IL-2Rbeta and IL-2Rgamma. They only acquire sensitivity after CD25 expression, which captures the cytokine and presents it to the IL-2Rbeta and IL-2Rgamma receptors. IL-2 Superkine (Fc) is an artificial variant of IL-2 called H9, containing mutations at positions L80F / R81D / L85V / I 86V / I92F. These mutations are located in the molecule's core that acts to stabilize the structure and to give it a receptor-binding conformation mimicking native IL-2 bound to CD25. These mutations effectively eliminate the functional requirement of IL-2 for CD25 expression and elicit proliferation of T cells. Compared to IL-2, the IL-2 superkine induces superior expansion of cytotoxic T cells, leading to improved anti-tumor responses in vivo, and elicits proportionally less toxicity by lowering the expansion of T-regulatory cells and reducing pulmonary oedema. The protein IL-2 Superkine (monomeric):Fc-KIH (human) (rec.) is produced by using two different vectors, one encoding for the IL-2 Superkine:Fc Knobs sequence (synthesizing a protein of 45kDa) and one encoding for the Fc Holes sequence (synthesizing a protein of 28kDa). Both vectors transfected into HEK293 cells produce both Fc molecules (Knobs-into-Holes technology, J.B. Ridgway, et al., Protein Eng. 9, 617 (1996)) required for dimerization of the Fc moieties and for secretion of the final protein IL-2 Superkine (monomeric):Fc-KIH (human) (rec.).
Keywords: IL2, IL-2, TCGF, Aldesleukin, Interleukin-2, T-cell growth factor
Supplier: AdipoGen Life Sciences
Supplier-Nr: AG-40B-0222

Properties

Application: Triggers far greater antitumor responses than native IL-2 in vivo but with lower toxicity
Conjugate: No
Host: Human cells
Species reactivity: human, mouse
MW: ~45+28 kD
Purity: >95% (SDS-PAGE)
Format: Lyophilized

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "IL-2 Superkine (monomeric):Fc-KIH (human) (rec.)"
Write a review
or to review a product.
Viewed